Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.455 USD | -0.30% | -5.21% | -35.09% |
05-10 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-21 | Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors | CI |